| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.008 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.096 | 0.008 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.091 | 0.009 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.081 | 0.009 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |